sired, asuitable amount of lidocaine hydrochloride.The solutions for intravenous injections or infusione may contain as carrier, for example, sterile water or, preferably, they may be in the form of sterile, aqueous, isotonic saline solutions.The compounds of the invention may be administered either as such as in the form of pharmaceutically acceptable salts or complexes.Examples of salts are acid